Introduction
Pharma packaging regulations are a set of principles and standards agreed upon for ensuring the safe packaging of pharma products. It includes the industry's best practices for successful packaging operations that result in the safe delivery of pharma products at the hands of its user by protecting the pharma product from all external and internal hazards such as environment, human handling, and extreme weather conditions.
Every market and country has its regulatory bodies that define packaging regulations for that particular market. Every pharma product manufacturer must comply with these regulatory body regulations. If it fails to comply with these regulations, the pharma product manufacturer will not allow it to sell its product in that market.
There are various regulatory bodies globally that take part in constituting packaging regulations. The pharma manufacturer is requires to comply with the regulations of body, in which it intends to produce or market its manufactured drug.
This article covers some basic pharma packaging regulations of China, the United States of America, and Europe.
Brief overview of NMPA EMA and FDA’s effort on packaging management
Regulatory bodies in the US, China, and Europe are responsible for regulating pharma products in terms of quality, safety, and efficiency. Because these markets offer great value and competitive prices, every pharma product manufacturer desires to sell their products in these markets. So, for this reason, regulatory bodies in these regions are responsible for ensuring the safety of pharma products.
Some ways that these regulatory bodies regulate the packaging operations of pharma products include the following.
To ensure that proper and relevant packaging material, process, and types are selected for a pharma product that ensures product safety and quality until it reaches the hands of patients or its intended user.
Pharma product is packed with all the relevant information.
Packaging dimensions are according to the classifications. The packaging can be easily opened and managed by the end-user
Packaging should provide anti-counterfeit and tamper-evident features.
Packaging should contain all the relevant labels and insertions.
To ensure packaging is safe and secure, test the final packed product using various test methods such as packaging integrity.
Packaging material is appropriately selected for a selected product.
The packaging indicates drug usage, with all the relevant details, such as manufacturing and expiry date.
Some common packaging regulations of an NMPA EMA and FDA
Let’s discuss some regulations for packaging in light of NMPA, FDA and EMA.
The pharma product manufacturer should arrange the correct packaging material.
Approved packaging material procedures, per GMP, must be in place.
Sample of packaging material for conducting various quality, safety, and compatibility tests must be taken by authorized persons with approved procedures.
Batch records of the packaging must be evaluated and signed by an authorized signatory before sending them to the quality department.
The quality department should ensure that packaging material should meet relevant registration requirements.
Direct contact between the operator's hands and the primary packaging material should be avoided.
Drug packaging areas should be indicated and l...
Read More
(All Rights Reserved)